Generating Evidence to Transform Care
At Resilience Care, our academic research is guided by one mission: generating meaningful clinical evidence to improve patient care. Across oncology, psychiatry, and gastroenterology, our studies validate the real-world impact of our digital health solutions on patient experience and outcomes.
Initiated and led
by our internal medical and research teams
Designed
Designed to validate our digital tools and patient-reported outcomes
Our Partners
Our proven track record speaks to the trust and impact we've built in the oncology community.
.png)
.png)
Current Resilience Care-Led Clinical Studies
A series of clinical studies led by Resilience Care, in collaboration with leading research centers worldwide, exploring the biological and clinical mechanisms underlying cancer, gastroenterology, and mental health conditions.
GC-102
IBD (Gastroenterology)
116
Patients
20
Sites
France
GC-102 : Mutlicentric Controled Trial in oncology
NCT Link : NCT07043036Primary objective
Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or Changing Advanced Therapy (GC-102).
The primary objective is to compare the healthcare resource utilisation of continuous monitoring at home using a digital remote patient monitoring solution compared to standard monitoring in patients with CD or UC initiating an advanced therapy OR undergoing a substantial change in the treatment of the disease. (superiority).
EC-102
Mood Disorders (Psychiatry)
594
Patients
50
Sites
France
EC-102 : Mutlicentric Controled Trial in Psychiatry
NCT Link : NCT07087353Primary objective
Efficacy of Remote Monitoring in Patients Treated for Moderate to Major Depressive Episodes (EC-102)
The primary objective is the 6‑month response rate, defined as a ≥50% reduction in the MADRS score at 6 months. Secondary objectives include remission, relapse, quality of life, and the health‑economic impact of the tool.